0 avis
Expression of a core 3 disialyl-Lex hexasaccharide in human colorectal cancers: A potential marker of malignant transformation in colon
Archive ouverte
Edité par CCSD ; American Chemical Society -
International audience. Cancer-associated alterations in cell surface and secreted glycoproteins have been catalogued for many years but many of the studies of alterations in mucin carbohydrate have relied on histochemical or immunohistochemical methods, with little direct chemical analysis. In this study, we analyzed the O-glycosylation pattern of MUC2 glycoprotein isolated from colorectal carcinomas, transitional mucosa and resection margins from three patients with blood group A, B and 0, respectively. After alkaline borohydride treatment, the released oligosaccharides were structurally characterized by nanoESI Q-TOF tandem mass spectrometry without prior fractionation or derivatization. As expected, we found an increased expression of sialyl-Tn antigen in the colonic cancer mucins. A more interesting feature was the increased expression of a core 3 sialyl-Lex hexasaccharide, NeuAcα2-3Galβ1- 4(Fucα1-3)GlcNAcβ1- 3(NeuAcα2-6)GalNAc in tumor, which appeared to compete with its sulfo-Lex counterpart in normal tissue, S03-3Galβ1-4(Fucα1-3)GlcNAcβ1-3(NeuAcα2-6)GalNAc. This antigen, whose structure was confirmed by NMR experiments, is based on a core 3 glycan and may be a potential marker for the malignant transformation of colonic cells. Unexpectedly, most of the glycans recovered in normal and carcinomas extracts were based on a sialylated core 3, GlcNAcβ1-3(NeuAcα2-6) GalNAcol. Moreover, the pattern of glycosylation was very similar between mucins isolated from each sample, the main differences related to the level of expression of the major oligosaccharides. The data obtained in this investigation may have value for future screening studies on colorectal cancer.
Consulter en ligne
Suggestions
Du même auteur
